The apical membrane of renal proximal tubular epithelial cells is the main controller of phosphate homeostasis, because it determines the rate of urinary P i excretion. The opossum kidney (OK) cell line is a good model for studying this function, but only NaPiIIa (NaPi4) has been identified to date as a P i transporter in this cell line. In this work, we have identified three additional P i transporters that are present in OK cells: NaPiIIc, PiT1 and PiT2. All three sequences are similar to the corresponding orthologues, but PiT1 is missing the first transmembrane domain.
INTRODUCTION
Inorganic phosphate homeostasis is achieved through the coordinated activity of intestinal absorption, bone storage and the renal excretion of surplus P i (for reviews, see Chang & Anderson, 2017; Marks, Debnam, & Unwin, 2010) . These three processes are the targets of a number of hormonal and nonhormonal regulatory mechanisms, which apparently act in a redundant manner. The evolutionary cost of the existence of so many regulatory mechanisms is justified not only by the physiological relevance of inorganic phosphate but also by the dangerous outcomes of P i homeostasis dysregulation and toxicity (e.g. Chang & Anderson, 2017; Komaba & Fukugawa, 2016) .
Of the aforementioned three processes, renal reabsorption/urinary excretion of P i is recognized as the main and fastest mechanism for achieving phosphate homeostasis, and it is a target of all regulators known to affect P i homeostasis. Most renal P i reabsorption takes place in the proximal tubule through the activity of sodium-coupled P i cotransporters expressed in the apical membrane of the epithelial cells. Two type II P i transporters, NaPiIIa and NaPiIIc (Forster & Werner, 2018; Forster, Hernando, Biber, & Murer, 2013) , and two type III P i transporters, PiT1 and PiT2 Sorribas, 2018) , are expressed in the proximal tubule. However, only NaPiIIa, NaPiIIc and PiT2 have been described in the apical brush-border membrane, and they are regulated by dietary P i deprivation in different ways (VillaBellosta et al., 2009b) . Therefore, in addition to the activity of many regulatory mechanisms, the presence of several P i transporters that are not regulated in a similar manner further complicates our ability to understand this important homeostatic function precisely.
For study of the cellular and molecular mechanisms of P i reabsorption, the most common in vitro model is the opossum kidney (OK) cell line. In this line, factors such as the kinetic characteristics of P i transport (including the response to pH changes), the regulation by parathyroid hormone and the P i concentration in the culture medium, and the expression of NaPiIIa are similar to the responses and characteristics observed in the proximal tubule (e.g. Malmström & Murer, 1986; Sorribas et al., 1994) . Nevertheless, although OK cells have helped us to understand some of the molecular mechanisms of Experimental Physiology. 2019;104:149-161.
wileyonlinelibrary.com/journal/ephNaPiIIa regulation, they represent a limited cell model, both because this model lacks a genome sequence of the original species (Didelphis virginiana) and because of the scarcity of commercial antibodies. In this respect, the various groups that are working in this area have been unable to generate functional and valid antibodies against the endogenous NaPiIIa (formerly NaPi4). One exception is Professor Lederer's group, which was able to generate a functional polyclonal antibody (Lederer, Sohi, Mathiesen, & Klein, 1998) .
In this work, we have attempted to overcome the aforementioned limitations regarding the use of OK cells when studying renal tubular proximal P i transport. Although the only P i transporter that had been identified and sequenced in these cells up to now was NaPiIIa (Sorribas et al., 1994) , we have now been able to sequence the three other types of sodium-coupled P i transporters in the kidney known to date:
NaPiIIc, PiT1 and PiT2. Sequences were analysed in silico for twodimensional (2D) modelling, and the various expressions of the four transporters were also studied as a function of culture confluence and the concentration of P i in the medium. The expressions were contrasted with the characteristics of the resulting transport, in combination with RNA interference, subsequently leading us to reach conclusions about the relevance of each transporter in the total P i uptake by these cells.
METHODS

Cell culture and transport assays
Opossum kidney proximal tubule (OK) cells, a permanent cell line originally obtained from a female American opossum kidney (Koyama, Goodpasture, Miller, Teplitz, & Riggs, 1978) , were grown in Dulbecco's modified Eagle's medium (DMEM)-Ham's F12 supplemented with 10% fetal calf serum (FCS), penicillin, streptomycin and L-glutamine at 37 • C in air supplemented with 5% CO 2 . At confluency, cells were made quiescent by incubating them in the same medium with FCS at 0.2% for 24 h. For various P i concentrations in the culture media, P i -free DMEM with 0.2% FCS was used, which was ultimately supplemented with 0.1, 1 or 2 mmol l −1 P i (from a combination of K 2 HPO 4 and KH 2 PO 4 for a final pH of 7.4). All culture reagents were from Gibco (Thermofisher Scientific, Waltham, MA, USA).
Transport assays were performed on plastic support, as described (Sorribas et al., 1994; Villa-Bellosta & Sorribas, 2009 
New Findings
• What is the central question of this study?
The opossum kidney (OK) cell line is the main in vitro model of proximal tubular P i transport, but it is incomplete because only the NaPiIIa P i transporter has been identified.
• What is the main finding and its importance?
We have cloned and characterized the P i transporters NaPiIIc, PiT1 and PiT2 from OK cells and have analysed the relevance of the four transporters to P i transport. All four transporters are involved in the upregulated P i transport of cells incubated using a low-P i medium, and only PiT1 is not involved in basal transport.
Homo sapiens to generate overlapping 5 ′ and 3 ′ ends of cDNA.
The sequence analysis and assembling were carried out using MacVector v.14.0 (MacVector, Inc, Cary, NC, USA). 
Pharmacological treatments
All chemicals were from Sigma-Aldrich (St Louis, MO, USA). Quiescent OK-P cells were incubated for 24 h in the presence or absence of either 1 mol l −1 actinomycin D or 0.01 mol l −1 triiodo-L-thyronine (T 3 ) and different concentrations of P i . Reagents were dissolved in dimethyl sulfoxide (DMSO), and the same amount of solvent was added to the control cells (0.1% final concentration; i.e. 1:1000 dilution). 
RNA interference
Cell membrane preparation and immunoblot analysis
After treatments, cells grown in 100 mm dishes were scraped into 5 ml of ice-cold PBS and centrifuged at 15000g for 10 minutes. The and was used as a control for the indicated experiments.
Statistics
All experiments were repeated three times, using triplicates per condition, and are shown as means ± SD. GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA) was used for statistical analysis. The significances of differences were determined by unpaired Student's t test or by one-way ANOVA with Tukey's post hoc test for multiple comparisons, depending on the experiment and the number of means. Differences were considered significant when the P values were < 0.05.
RESULTS
Cloning of PiT1, PiT2 and NaPiIIc from OK cells
RACE assays provided the complete coding region sequence of PiT1
(677 amino acids) and PiT2 (653 amino acids). In the case of NaPiIIc, only the 5 ′ -RACE was obtained, which included the first 422 amino acids. A 2D model of PiT1 is shown in Figure 1a , with several common and uncommon characteristics revealed after an alignment with various orthologues. Common characteristics include a glycosylation PiT2 from OK cells shows a more conserved structure, including the 12 TMDs and both ends located extracellularly, with N-glycosylation located at N81, six potential phosphorylation sites in the large intracellular loop and the two pfam01384 domains (Figure 1d ).
For the 2D modelling of NaPiIIc, the sequence of the 422 amino acids identified with 5 ′ -RACE was fused in silico to amino acids 423-621 from M. domestica (accession no. XP_007475507). The added sequence is shown as red residues in Figure 2 . A hydropathy analysis of the resulting chimeric protein provided the classical 12-TMD model (Forster, Hernando, Biber, & Murer, 2012) . A more recent work has suggested a very interesting three-dimensional (3D) model of NaPiIIa (Fenollar-Ferrer et al., 2014 ) based on hydropathic, fold homology with the Na + -coupled dicarboxylate transporter from Vibrio cholerae (Mancusso, Gregorio, Liu, & Wang, 2012) . We have not developed a 3D model for OK NaPiIIc because it is beyond the scope of this work and because our sequence of NaPiIIc is incomplete. Nevertheless, Figure 2 shows a combination of a 2D model of NaPiIIc with several modifications and characteristics derived from the 3D model of NaPiIIa 
Relevance of type II versus type III P i transport
Beginning with a concentration of 1 mmol l −1 P i , OK cells were incubated with 0.1 or 2 mmol l −1 P i in DMEM for 24 h. Figure 3a shows that, as expected, the uptake of OK cells incubated with 0.1 mmol l −1 P i was twice the uptake with 0.05 mmol l −1 32 P i at pH 7.4 compared with cells maintained in DMEM with 2 mmol l −1 P i . The activity of the type II and III P i transporters is very sensitive to the pH of the medium because they preferentially transport HPO 4 2− or H 2 PO 4 − , respectively, and because the relative abundance of these P i species is mainly dependent on the pH. In fact, at pH 7.5 monovalent P i (H 2 PO 4 − )
is ∼17%, whereas divalent P i (HPO 4 2− ) is ∼83%. The effect of protons as competitors with the sodium binding sites has also been suggested (Hartmann et al., 1995) . To study the uptake of each species more specifically, the same type of experiment was performed at pH 6.0 and 8.5, given that at pH 6.0, 86% of P i is H 2 PO 4 − , whereas at pH 8.5, 98%
of P i is HPO 4 2− (see Candeal, Caldas, Guillén, Levi, & Sorribas, 2017) .
The uptake at pH 6.0 was approximately 20-40% of the uptake at pH 8.5, at either concentration of P i , thereby showing the known preference of OK cells for divalent P i (Figure 3a) . To emphasize the linearity of the pH effect on P i uptake, the regression lines of P i uptake as a function of pH are also shown for both P i concentrations, and they reveal no saturation at the pH range of the experiment. At all three pH values, the uptake of 0.05 mmol l −1 32 P i was approximately double in cells adapted to 0.1 mmol l −1 P i , compared with 2 mmol l −1 P i . Given that type III P i transporters (PiT1 and PiT2) have a preference for monovalent P i and that type II P i transporters (NaPiIIa and NaPi2c) have a preference for divalent P i , the pH results suggest that in OK cells and our experimental conditions, type II activity is double that of type III at 0.05 mmol l −1 P i . However, the results also show that the adaptation of type III P i transport also takes place to the same extent as type II.
To confirm these conclusions and discard the presence of additional, unknown P i transporters, we also used 5 mmol l −1 phosphonoformic acid (PFA) as an inhibitor of type II transporters (Figure 3b ). At pH 6.0, the presence of PFA did not significantly inhibit P i uptake, but at pH 8.5, PFA completely prevented adaptation to incubation with 0.1 mmol l −1 P i for 24 h, and it maintained the uptake at the basal level of 2 mmol l −1 P i .
Basal mRNA expression of P i transporters
The mRNA expression of the various P i transporters was also assayed to test the predictions of the functional assays summarized in the preceding section. In basal conditions (i.e. 100% confluent OK cells grown in DMEM-F12 medium), NaPiIIa and NaPiIIc were the most abundant P i transporters, and PiT2 was the least-expressed RNA (Figure 4a ). 
This general expression pattern was maintained in cells incubated in
Role of RNA transcription in P i adaptation
Next, we analysed whether the adaptation to low P i was dependent on Expressions of the P i transporters with respect to PiT2 at the indicated percentages of confluence in cells grown in 1 mM P i . A logarithmic scale on the ordinate axis is used owing to the high number of expression time differences. PiT1 and PiT2 expressions diminish and NaPiIIa and NaPiIIc expressions increase when the OK cell culture is more confluent
Changes in RNA abundance during adaptation to P i concentrations in OK cells
To check whether the effects of actinomycin D on P i transport were attributable, at least in part, to changes in the RNA abundance of any of the four transporters, the corresponding RNA levels were determined by real-time PCR (Figure 6a ). The NaPiIIa RNA abundance increased in cells incubated with 0.1 mmol l −1 P i , and this increase was resistant to actinomycin D; after 24 h of treatment, the abundance and adaptation effects were similar. The NaPiIIc RNA expression was also increased by low phosphate, and this increase was also resistant to actinomycin D.
However, in the presence of the transcription inhibitor, actinomycin D, the expression of NaPiIIc RNA was reduced by half in cells maintained with either 0.1 or 2 mmol l −1 P i .
We could not find clear and significant increased expressions of PiT1 or PiT2 RNAs. Nevertheless, these transcripts were the most ActD:
Effect of inhibition of transcription on adaptation to low and high (0.1 and 2 mmol l −1 P i ) phosphate concentrations at the indicated pH. Actinomycin D (ActD) prevents adaptation to low P i when P i transport is measured at pH 6.0. However, at pH 8.5 the effect of transcription inhibition on adaptation is not observed, although actinomycin D does reduce P i uptake at both concentrations of P i . Asterisks indicate significantly different means by ANOVA (P < 0.05) sensitive to actinomycin D treatment; PiT1 expression was reduced by six times and PiT2 by 18 times.
Owing to the failure to obtain functional and reliable polyclonal antibodies (see Methods), we only used an anti-NaPiIIa antibody from OK cells donated by Professor Eleanor Lederer .
We checked the correlation between the RNA and the protein of NaPiIIa in cells that were incubated for 24 or 48 h with either 0.1 or 2 mmol l −1 P i and actinomycin D (Figure 6b) . At 24 h, actinomycin D did not clearly modify the expression of NaPiIIa. However, after 48 h the expression was reduced to one-third of the corresponding initial expression, at both 0.1 and 2 mmol l −1 P i , and a modest adaptation persisted.
To confirm the accuracy of the determinations of RNA changes shown in Figure 6a , the abundances of the four P i transporter RNAs were also measured after treating OK cells with 10 nmol l −1 triiodo-L-thyronine (T 3 ) for 24 h, as a positive control (Alcalde et al., 1999; . Figure 6c shows that, in the case of NaPiIIa and NaPiIIc, T 3 induced 1.5 times the expression of each transporter, whereas PiT1 and PiT2 were unaffected in these cells.
Specific relevance of P i transporters in basal P i transport in OK cells
Given that the effects of actinomycin D on P i transport and the adaptation thereof can also be attributable to inhibiting the expression of many other proteins, such as regulators, receptors or scaffold proteins, we selectively inhibited the expression of transporters by using siRNAs (Figure 7 ). The efficiency of the interferences varied considerably among the experiments, ranging from 70 to >90% after 48 h (Figure 7a ). The percentages of inhibitions were similar, despite the initial differences in transporter expressions. These expressions were similar whether they were transfected with scrambled siRNAs (Figure 7b ) or were non-transfected (Figure 4; 100%) . Even when the cells were transfected in a culture at 80% confluence, the cells were 100% confluent at the moment of the final assay owing to the necessary incubation of the cells for 48 h in DMEM-F12
supplemented with 10% FCS. This explains the difference between the RNA expressions of Figures 7b and 4b at 80% confluence.
The results of specific P i transporter knockdown were absolutely unexpected. Functional assays after RNA interference were performed at different pH values to facilitate the interpretation of results. For PiT1 and PiT2 siRNA transfections, P i transport was measured at pH 6.0 after 48 h, whereas for NaPiIIa and NaPiIIc, an uptake assay was performed at pH 8.5. Despite the higher expression of PiT1 over PiT2, siRNA inhibition of the expression of PiT1 did not cause any change in P i transport (Figure 7c ). However, RNA expression inhibition of PiT2 caused a 39% reduction in P i transport, despite the lower expression of PiT2 compared with PiT1 and the other P i transporters.
Regarding type II transporters, the results of inhibition were similar for both NaPiIIa and NaPiIIc ( Figure 7d ). P i transport after NaPiIIa knockdown was reduced by 65%, whereas the interference with NaPiIIc resulted in a 59% reduction of P i uptake. In the case of NaPiIIa, the inhibition of RNA expression with siRNA was accompanied by a reduction of protein expression, as confirmed by western blot (Figure 7e ).
Specific relevance of P i transporters in OK cell adaptation
To ascertain the role of the various P i transporters in adapting to a low or high P i concentration in the culture medium, we transfected the cells (80% confluence) with the various siRNAs, and after 48 h, the cells were incubated with 0.1 or 2 mmol l −1 P i for 24 h. The apparently unexpected results are shown in Figure 8 . In all four cases, siRNA not only prevented adaptation to low P i (0.1 mmol l −1 ), but it also further reduced the uptake level in cells incubated with 2 mmol l −1 P i . This reduction below the level of 2 mmol l −1 P i was significant only in the case of NaPiIIa and NaPiIIc. 
DISCUSSION
In this work, we provide new knowledge about the renal mechanisms of proximal tubular P i transport, and the new findings can be divided into two main parts. First, we have identified the sequences of the missing P i transporters in OK cells (NaPiIIc, PiT1 and PiT2), and second, we have studied the relevance of the various transporters to the total P i uptake in OK cells and during adaptation. The main difference was related to PiT1, because the first 39 amino acids were very different with respect to the remaining orthologues, resulting in high hydrophilicity and low hydrophobicity of the amino-terminus, according to the hydropathy results (Figure 1c) .
Consequently, the first TMD of the accepted model of PiT1 in other species is not predicted for OK cell PiT1, and therefore, the model changes from 12 TMDs (Bøttger & Pedersen, 2011; Ravera et al., 2013) to 11 TMDs.
All the other characteristics present in PiT1 and PiT2 from OK cells have been described previously. This includes N-glycosylation and critical amino acids for P i transport in the external region between TMDs 1 and 2 in PiT1 and TMDs 2 and 3 in PiT2 (Ravera et al., 2013) , in addition to the two pfam01384 domains, the PD1131 homology domains (Salaün, Gyan, Rodrigues, & Heard, 2002) and the PiT signature sequences (Bøttger & Pedersen, 2011) .
All three members of the type II family (Slc34a1, Slc34a2 and Slc34a3) of P i transporters also showed a similar primary structure, and with respect to the secondary structure, a 12-TMD 2D model has been consolidated over the years (for a review, see Forster et al., 2012) . The OK NaPiIIc does not seem to be an exception, but this cannot be confirmed until the complete sequence is known, given that we identified only the first 422 amino acids (Figure 2) . Based on the amino acid sequences, we prepared polyclonal antibodies for the new transporters, but none of them provided specific and reliable signals in the western blot analysis. The determination of NaPiIIc from OK cells has been reported previously using an antibody raised against a peptide corresponding to the C-terminus of NaPiIIc from M. domestica (Ito et al., 2010) . The sequences of the C-ends of both opossum NaPiIIc are most probably very similar or even identical.
Nevertheless, because the C-terminus of the American opossum was missing in our 3 ′ -RACE and because we also lacked antibodies against PT1 and PiT2, we decided to homogenize the results and focus on the functional and RNA regulation of all four P i transporters. A striking characteristic of the OK culture is the great variability as a function of the proliferation state and confluency (Figure 4) . The more confluent the cells are, the higher the expression of type II, whereas the converse is true for type III, in which expression is lower to the extent that confluency is greater. In confluent OK cells, the expression of PiT2 is negligible, and in highly proliferating cells the expressions of NaPiIIa and NaPiIIc are extremely low. The characteristics of P i transport in confluent OK cells are typical of the proximal tubule, i.e. type II P i transport, meaning that it is increased by an alkaline pH and is inhibited by PFA (Figure 3 ). Only at pH 6.0, when the monovalent P i species is most abundant, is type III P i transport revealed, which is resistant to PFA inhibition (Figure 3b ). At this confluent state, NaPiIIa and NaPiIIc are most abundant, but PiT1 is also significantly expressed (Figure 4) , which is consistent with the results in both figures; transport characteristics and RNA expression.
In addition to NaPiIIa (e.g. Markovich et al., 1995; Pfister et al., 1998; Thomas, Wagner, Biber, & Hernando, 2016; Villa-Bellosta & Sorribas, 2009 ), adaptation to a low P i concentration in a culture medium also affects NaPiIIc RNA in OK cells (Figure 6 ). In the case of NaPiIIa and most probably regarding NaPiIIc, the increase in mRNA seems to be attributable to an increased stability of RNA rather than increased transcription. We have also quantified the abundance of NaPiIIc mRNA after treatment with T 3 , a hormone known to increase the abundance of NaPiIIa transcriptionally in OK cells and in rats (Alcalde et al., 1999; Sorribas et al., 1995) . The NaPiIIa RNA increased as expected (Figure 6c ), and the increase was similar for NaPiIIc but was absent in the case of PiT1 and PiT2.
With respect to the molecular mechanisms of chronic adaptation to a low P i concentration in culture medium, previous transport assays had been performed at pH 7.4, and only the RNA of NaPiIIa (NaPi4) was evaluated (e.g. Markovich et al., 1995) . By inhibiting transcription with actinomycin D, we have, in part, confirmed those previous results. NaPiIIc and both PiT1 and PiT2 (mainly) are very sensitive to actinomycin D treatment, and after 24 h their RNA levels drop dramatically and prevent P i transport adaptation when measured at pH 6.0. These results strongly suggest that the half-life of NaPiIIa RNA is the longest of all four transcripts.
Using siRNA, these conclusions were confirmed only in part. The main problem with this technology is that, to reach acceptable transfection efficiency, the OK cell culture needs to be non-confluent, and the expression of P i transporters will differ considerably from the time of confluence, as we have shown. Moreover, not only does siRNA prevent the initiation of nascent RNAs, but the final and steadystate abundance of the specific transcripts is also affected. Taking these limitations into account, the inhibition of the specific transcripts revealed that P i transport was not affected by PiT1 siRNA; that PiT2 interference moderately affected P i transport, despite the low expression; and that NaPiIIa and NaPiIIc siRNAs strongly affected P i transport in a similar, although not completely (Figure 7) . The non-effect by PiT1 siRNA could be explained by the long half-life of the protein, an issue that can be addressed only when a good antibody is obtained. Also, PiT1 has additional functions, such as proliferation/apoptosis (Beck et al., 2009; Kongsfelt, Byskov, Pedersen, & Pedersen, 2014) and P i sensing (Bon et al., 2018; Salaün et al., 2002) , and at least in vascular smooth muscle cells, the protein is also expressed intracellularly (Villa-Bellosta, Levi, & Sorribas, 2009a) .
The effects of siRNAs were also studied regarding the ability of cells to adapt to the concentration of P i in the culture medium. The siRNA treatment affected the process of adaptation in all four cases, but with important differences (Figure 8 ). NaPiIIa siRNA prevents adaptation to 0.1 mmol l −1 of P i when compared with scrambled siRNA-treated cells incubated with 2 mmol l −1 P i , but when compared with NaPiIIa siRNA-treated cells incubated with 2 mmol l −1 P i , adaptation persists.
The effect of siRNA on NaPiIIc was similar but more modest. The PiT1 and PiT2 siRNAs also completely prevented the adaptation of P i transport to a low P i concentration. Given that the expressions of both transporters are very low, a likely explanation is that these transporters have other functions in addition to P i transport, as indicated above.
To summarize, confluent OK cells show a combination of type II and type III P i transport, with major expression of NaPiIIa and NaPiIIc, minor expression of PiT1 and negligible expression of PiT2. NaPiIIa, NaPiIIc, PiT1 and PiT2 are all involved in the handling of P i by these cells, but they seem to have very different roles at the basal transport rate and during increased transport induced by a low P i concentration.
